We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current VOR market cap is 81.37M. The company's latest EPS is USD -1.7382 and P/E is -0.69.
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -30.42M | -32.17M | -35.32M | -28.12M | -32.33M |
| Net Income | -28.43M | -29.98M | -33.19M | -26.26M | -30.8M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -10.42M | -43.37M | -69.02M | -93.42M | -126.04M |
| Net Income | -12.61M | -49.26M | -70.13M | -92.09M | -117.86M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 277.53M | 250.99M | 223.02M | 198.13M | 167.03M |
| Total Liabilities | 47.32M | 46.54M | 48.24M | 47.4M | 44M |
| Total Equity | 230.22M | 204.45M | 174.78M | 150.72M | 123.04M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 9.83M | 75.91M | 242.59M | 299.37M | 198.13M |
| Total Liabilities | 2.19M | 27.64M | 26.33M | 48.76M | 47.4M |
| Total Equity | -17.43M | -59.07M | 216.26M | 250.61M | 150.72M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -24.27M | -48.37M | -76.27M | -100.29M | -30.47M |
| Investing | 6.5M | 20.14M | 60.67M | 71.01M | 43.97M |
| Financing | 2.52M | 2.74M | 2.91M | 2.94M | 96k |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -9.86M | -36.29M | -69.14M | -85.14M | -100.29M |
| Investing | -748k | -4.16M | -91.65M | -94.09M | 71.01M |
| Financing | 17.7M | 82.53M | 232.91M | 117.14M | 2.94M |
| Market Cap | 81.37M |
| Price to Earnings Ratio | -0.69 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 2.59 |
| Price to Book Ratio | 0.54 |
| Dividend Yield | - |
| Shares Outstanding | 67.81M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 0.08 (6.61%) |
| Company Name | Vor Biopharma Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.vorbio.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
